HEALTHCROSSCUT SEATTLE
Some Medicare beneficiaries get weight loss drug discount
The use of GLP-1 drugs for weight loss has increased significantly, with 11% of adults currently using them, up from 3% two years ago. Medicare has enabled some patients to access these drugs, potentially driving further adoption.
Mentioned
Related Signal
Adjacent reporting
- A new Medicare option for weight loss drugs is coming: Here's what to know
- A new Medicare option for weight loss drugs is coming: Here's what to know
- GLP-1 use reaches new high in US
- Research shows weight-loss drugs may also reduce cancer risk
- Insurance increasingly dropping weight loss drugs like Wegovy, Zepbound